AURO LABORATORIES
|
The Current P/E Ratio of AURO LABORATORIES is 149.93.
| Share Price | ₹255.6 | Nov 21,2025 |
| Market Cap | ₹158.5 Cr | |
| Earnings-TTM | ₹1.1 Cr | TTM-Standalone Results |
| Price/Earnings | 149.93x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AURO LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹158.5 Cr] as on Nov 21,2025
(/) Earnings [ ₹1.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 149.93x ]
Thus, for AURO LABORATORIES , the investors are currently willing to pay 149.93 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AURO LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AURO LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of AURO LABORATORIES
PE Ratio Performance Analysis for AURO LABORATORIES
- AURO LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.80x.
- AURO LABORATORIES 's operated at median p/e ratio of 13.95x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AURO LABORATORIES 's p/e ratio peaked in Mar2025 at 78.15x.
- AURO LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 7.04x.
How does AURO LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AURO LABORATORIES | 1.06 | 149.93 | 158.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.60 | 427,034.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.09 | 169,211.0 |
| CIPLA LTD | 5,453.86 | 22.38 | 122,082.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 58.35 | 124,875.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.16 | 103,873.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.39 | 92,581.7 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.70 | 93,026.3 |
| LUPIN LTD | 4,347.53 | 21.31 | 92,663.3 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.30 | 70,004.0 |
| ABBOTT INDIA LTD | 1,508.95 | 41.62 | 62,806.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AURO LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.16x |
| Max industry PE | 149.93x |
| Median industry PE | 40.60x |
| Average industry PE | 46.53x |
You may also like the below Video Courses